(19)
(11) EP 4 815 921 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898825.5

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 9/10(2006.01)
A61K 9/14(2006.01)
A61K 38/00(2006.01)
A61K 9/00(2006.01)
A61K 47/14(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0019; A61K 47/14; A61K 9/10; A61K 9/1623
(86) International application number:
PCT/US2024/057892
(87) International publication number:
WO 2025/117847 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605430 P

(71) Applicant: Serán Bioscience, LLC
Bend, Oregon 97701 (US)

(72) Inventors:
  • SCHLESINGER, Erica
    Sisters, Oregon 97759 (US)
  • KASTANTIN, Mark
    Bend, Oregon 97703 (US)
  • CHUNG, Cindy
    Bend, Oregon 97702 (US)
  • COLLINS, Mary
    Bend, Oregon 97701 (US)
  • SMITHEY, Dan
    Bend, Oregon 97702 (US)
  • CORRADO, Tanner
    Bend, Oregon 97701 (US)

(74) Representative: Maikowski & Ninnemann Patentanwälte Partnerschaft mbB 
Postfach 15 09 20
10671 Berlin
10671 Berlin (DE)

   


(54) METHODS AND SYSTEMS FOR INJECTABLE FORMULATIONS